Dr. Nasser Hanna, Indiana University Health, discusses the possible role of immunotherapy in locally advanced NSCLC.

A new study from the National Institutes of Health is being published in the journal of Clinical Oncology and demonstrates that elevated levels of C-Reactive Protein (CRP), a biomarker of chronic inflammation, is associated with lung cancer.